Retatrutide is an investigational once-weekly injectable triple receptor agonist that activates GLP-1, GIP, and glucagon receptors simultaneously, producing greater appetite suppression and energy expenditure than single or dual receptor agonists
Lifestyle Modifications Adopting healthy lifestyle changes can significantly reduce the risk of pancreatitis: Balanced Diet: Focus on a diet rich in fruits, vegetables, whole grains, lean proteins, and healthy fats
[1] [2] Once in use, storage requirements vary by product: some can be kept at room temperature (below 86F or 30C) for specific periods ranging from 14 to 56 days depending on the medication
The FDA has not added blood clots to the semaglutide label but is investigating the signal
Individual Variation Response to both Retatrutide and Mounjaro varies substantially between individuals
In some individuals, this physiological change may increase the likelihood of gastro-oesophageal reflux symptoms, where stomach acid travels back up into the oesophagus
